Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q1 2025 Earnings

5MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.47

-0.42

-0.38

-0.33

Details

Expected EPS

-0.432453

Actual EPS

-0.44

Surprise EPS

-0.01

Surprise Percent

+1.75%

Description

Fate Therapeutics (FATE) has reported earnings of -0.44 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.